23.58
Schlusskurs vom Vortag:
$23.94
Offen:
$23.76
24-Stunden-Volumen:
28,226
Relative Volume:
0.15
Marktkapitalisierung:
$399.62M
Einnahmen:
$978.76M
Nettoeinkommen (Verlust:
$-286.52M
KGV:
-1.3613
EPS:
-17.3212
Netto-Cashflow:
$-31.63M
1W Leistung:
-3.08%
1M Leistung:
-33.65%
6M Leistung:
+24.04%
1J Leistung:
-57.94%
Claritev Corp Stock (CTEV) Company Profile
Firmenname
Claritev Corp
Sektor
Branche
Telefon
212-780-2000
Adresse
7900 TYSONS ONE PLACE, MCLEAN
Compare CTEV vs VEEV, TEM, BTSG, HNGE, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CTEV
Claritev Corp
|
23.58 | 399.62M | 978.76M | -286.52M | -31.63M | -17.32 |
|
VEEV
Veeva Systems Inc
|
311.68 | 50.46B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
70.10 | 12.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
62.80 | 12.43B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HNGE
Hinge Health Inc
|
105.14 | 8.48B | 646.34M | -512.40M | 202.76M | -6.6871 |
|
HQY
Healthequity Inc
|
92.68 | 7.67B | 1.34B | 230.70M | 440.96M | 2.6695 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-05-29 | Eingeleitet | Canaccord Genuity | Buy |
| 2026-04-24 | Eingeleitet | Barclays | Overweight |
| 2026-01-12 | Eingeleitet | Guggenheim | Buy |
| 2026-01-09 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-10-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-05-29 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Neutral |
| 2022-12-13 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-07-12 | Eingeleitet | Goldman | Neutral |
| 2021-10-04 | Fortgesetzt | Citigroup | Buy |
| 2021-04-07 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-19 | Eingeleitet | Barclays | Equal Weight |
Alle ansehen
Claritev Corp Aktie (CTEV) Neueste Nachrichten
Claritev Corporation (CTEV) stock price, news, quote and history - Yahoo Finance UK
Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom? - Zacks Investment Research
Claritev: Revenue Growth Is Back, Cash Flow Is The Next Test (NYSE:CTEV) - Seeking Alpha
A Look at Claritev Corp (CTEV) After 11.3% Gain -- GF Value $28. - GuruFocus
Three entities report no Claritev (CTEV) shares, including a private equity investment arm. - stocktitan.net
Claritev Corp (CTEV) Shares Fall 3.7% -- What GF Score of 61 Tel - gurufocus.com
Form 144 CLARITEV CORPORATION For: 27 September By Investing.com - Investing.com Canada
Calif. Appeals Court Revives Antitrust Suit Against Claritev - Law360
Claritev Corporation (CTEV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Douglas Michael Garis Sells 9,025 Shares of Claritev (NYSE:CTEV) Stock - MarketBeat
Claritev : Five Shifts Reshaping TPA Cost Management - marketscreener.com
Claritev (CTEV) CFO sells stock under pre-set plan - Stock Titan
CTEV Looks 10.5% Overvalued on GF Value™ - GuruFocus
Claritev Corporation Is Selected By General Dynamics Information Technology To Support CDC?s World Trade Center Health Program - marketscreener.com
Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program - Business Wire
Planned Claritev (NYSE: CTEV) stock sale tops $278K - Stock Titan
Claritev Corporation Class A Common Stock (NYSE:CTEV) Stock Quote - The Chronicle-Journal
Claritev Corporation (CTEV) Stock Analysis: Unpacking a 44.45% Upside Potential in Healthcare Innovation - DirectorsTalk Interviews
Claritev Corp (CTEV) Stock Down 5.5% but Still Overvalued -- GF Score: 63/100 - GuruFocus
Claritev Releases 2025 Corporate Responsibility Report - Business Wire
Claritev Releases 2025 Corporate Responsibility Report - Yahoo Finance
New Claritev (CTEV) director gets 2,880-share RSU award - Stock Titan
Claritev Appoints Meta AI Research Scientist Ben Letham to Board - citybiz
Claritev Appoints Ben Letham to its Board of Directors - finance.yahoo.com
A Meta AI researcher joins Claritev’s board - Stock Titan
Claritev (NYSE:CTEV) Trading Up 4%Time to Buy? - MarketBeat
Claritev Cares Helps Rural Patients Get Critical Care Closer to Home - Stock Titan
Claritev Cares Helps Rural Patients Get Critical Care Closer to Home - finance.yahoo.com
Claritev’s (CTEV) Profit Picture Brightens, But Its Cash Cushion Shrinks - finance.yahoo.com
Bank of America Corp DE Purchases 58,133 Shares of Claritev $CTEV - MarketBeat
Claritev (NYSE:CTEV) CEO Buys 4,500 Shares of Stock - MarketBeat
Claritev CEO Travis Dalton buys $249,663 in company stock By Investing.com - Investing.com South Africa
Claritev CEO Travis Dalton buys $249,663 in company stock By Investing.com - Investing.com India
Claritev CEO Travis Dalton buys $249,663 in company stock - Investing.com
Claritev CEO Travis Dalton buys $249,663 in company stock By Investing.com - Investing.com Canada
Travis Dalton Purchases 1,950 Shares of Claritev (NYSE:CTEV) Stock - MarketBeat
Claritev (CTEV) CEO adds 6,450 shares via spouse IRA - Stock Titan
Claritev (NYSE:CTEV) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is Claritev Corp (CTEV) Overvalued After 9.4% Rally? GF Value Sa - GuruFocus
CTEV Maintained by Barclays -- Price Target Raised to $40.00 - GuruFocus
Claritev (NYSE:CTEV) SVP Tiffani Misencik Sells 8,850 Shares - MarketBeat
Claritev Corp (CTEV) exec sells 8,850 shares, holds 123,723 - Stock Titan
Claritev (NYSE:CTEV) Shares Gap DownHere's Why - MarketBeat
Claritev Chief Growth Officer Tiffani Misencik sells 8,850 shares worth $354,592.95 - Bitget
Claritev says Marpai expands contract for pre- and post-payment claims integrity services - Bitget
CTEV Looks 33.2% Overvalued on GF Value™ - GuruFocus
Marpai expands Claritev agreement for payment integrity By Investing.com - Investing.com Australia
Marpai expands Claritev agreement for payment integrity By Investing.com - Investing.com South Africa
Marpai expands Claritev agreement for payment integrity - Investing.com
Marpai expands beyond network access—but what comes next? - Stock Titan
Finanzdaten der Claritev Corp-Aktie (CTEV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Claritev Corp-Aktie (CTEV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Douglas Garis | Officer |
Sep 21 '26 |
Proposed Sale |
30.81 |
9,025 |
278,060 |
0 |
| Dalton Travis | Pres., CEO & Executive Chair |
Aug 28 '26 |
Buy |
38.48 |
1,950 |
75,040 |
52,322 |
| Dalton Travis | Pres., CEO & Executive Chair |
Aug 27 '26 |
Buy |
38.81 |
4,500 |
174,623 |
50,372 |
| TIFFANI MISENCIK | Officer |
Aug 14 '26 |
Proposed Sale |
40.07 |
8,850 |
354,592 |
0 |
| Misencik Tiffani | SVP, Chief Growth Officer |
Aug 14 '26 |
Sale |
40.07 |
8,850 |
354,593 |
123,723 |
| WILLIAM MINTZ | Officer |
Aug 10 '26 |
Proposed Sale |
34.24 |
8,431 |
288,677 |
0 |
| Mintz William B. | SVP, Chief Strategy Officer |
Aug 10 '26 |
Sale |
34.24 |
8,431 |
288,677 |
71,195 |
| Carol Nutter | SVP, Chief People Officer |
Jun 09 '26 |
Buy |
28.41 |
875 |
24,856 |
46,941 |
| Prince John Michael | Director |
May 19 '26 |
Buy |
16.00 |
10,000 |
160,000 |
31,662 |
| Kim Michael | EVP, Chief Digital Officer |
May 18 '26 |
Buy |
16.65 |
3,000 |
49,950 |
185,878 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):